Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

229 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer.
Parr C, Watkins G, Jiang WG. Parr C, et al. Int J Mol Med. 2004 Nov;14(5):779-86. doi: 10.3892/ijmm.14.5.779. Int J Mol Med. 2004. PMID: 15492845
The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor.
Davies ML, Parr C, Sanders AJ, Fodstad O, Jiang WG. Davies ML, et al. Among authors: parr c. Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):75-80. Cancer Genomics Proteomics. 2010. PMID: 20335521
Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications.
Davies SR, Davies ML, Sanders A, Parr C, Torkington J, Jiang WG. Davies SR, et al. Among authors: parr c. Int J Oncol. 2010 May;36(5):1129-36. doi: 10.3892/ijo_00000595. Int J Oncol. 2010. PMID: 20372786
Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
Rmali KA, Watkins G, Harrison G, Parr C, Puntis MC, Jiang WG. Rmali KA, et al. Among authors: parr c. Eur J Surg Oncol. 2004 Nov;30(9):948-53. doi: 10.1016/j.ejso.2004.07.023. Eur J Surg Oncol. 2004. PMID: 15498639
Hepatocyte growth factor/scatter factor and prostate cancer: a review.
Hurle RA, Davies G, Parr C, Mason MD, Jenkins SA, Kynaston HG, Jiang WG. Hurle RA, et al. Among authors: parr c. Histol Histopathol. 2005 Oct;20(4):1339-49. doi: 10.14670/HH-20.1339. Histol Histopathol. 2005. PMID: 16136515 Review.
Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
Parr C, Jiang WG. Parr C, et al. Int J Oncol. 2003 Aug;23(2):533-9. doi: 10.3892/ijo.23.2.533. Int J Oncol. 2003. PMID: 12851706
Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
Parr C, Jiang WG. Parr C, et al. Int J Oncol. 2001 Oct;19(4):857-63. Int J Oncol. 2001. PMID: 11562767
Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention.
Parr C, Jiang WG. Parr C, et al. Histol Histopathol. 2001 Jan;16(1):251-68. doi: 10.14670/HH-16.251. Histol Histopathol. 2001. PMID: 11193201 Review.
Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4.
Hiscox S, Parr C, Nakamura T, Matsumoto K, Mansel RE, Jiang WG. Hiscox S, et al. Among authors: parr c. Breast Cancer Res Treat. 2000 Feb;59(3):245-54. doi: 10.1023/a:1006348317841. Breast Cancer Res Treat. 2000. PMID: 10832594
Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
Parr C, Hiscox S, Nakamura T, Matsumoto K, Jiang WG. Parr C, et al. Int J Cancer. 2000 Feb 15;85(4):563-70. Int J Cancer. 2000. PMID: 10699931
229 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback